Conditional Antimicrobial Peptide Therapeutics

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Antimicrobial peptides (AMPs) constitute a promising class of alternatives to antibiotics to curb antimicrobial resistance. Nonetheless, their utility as a systemic agent is hampered by short circulation time and toxicity. Infection sites, analogous to tumors, harbor an aberrant microenvironment that has the potential to be exploited to develop conditionally activated therapeutics with an improved therapeutic index. In particular, we identified strategies to prolong systemic circulation of small, cationic AMPs in a mouse model of bacterial pneumonia. Specifically, we report an albumin-binding domain (ABD)-AMP conjugate as a long-circulating conditional AMP therapeutic with a masked activity that can be liberated by proteases in the infected tissue microenvironment. Our systemically administered conjugate enhanced the pulmonary delivery of active AMP while also reducing AMP exposure to other off-target organs. Importantly, this reduction in off-target exposure improved the safety profile of the AMP. The framework we present can be generalized to quantify and optimize the performance of this emerging class of conditional therapeutics.
Funding Information
  • National Institute of Environmental Health Sciences (P30-ES002109)
  • National Cancer Institute (P30-CA14051)
  • National Institute of Allergy and Infectious Diseases (K99 EB28311, R01 AI132413, U19 AI142780)

This publication has 46 references indexed in Scilit: